Processes using amino acid dehydrogenases and ketoreductase-based cofactor regenerating system

US2016281119A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016281119-A1
Application numberUS-201615184242-A
CountryUS
Kind codeA1
Filing dateJun 16, 2016
Priority dateFeb 10, 2010
Publication dateSep 29, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to the use of an amino acid dehydrogenase in combination with a cofactor regenerating system comprising a ketoreductase. In particular embodiments, the process can be used to prepare L-tert-leucine using a leucine dehydrogenase.

First claim

Opening claim text (preview).

What is claimed is: 1 . A process for converting a compound mixture of formula IId which comprises a substrate for an amino acid dehydrogenase to a composition of formula I and a chiral amino acid of formula IIa: comprising contacting the compound mixture of formula IId with an enantioselective amino acid dehydrogenase in a reaction medium comprising NAD + /NADH or NADP + /NADPH and a cofactor recycling system comprising a ketoreductase and a lower alkyl ketone, under conditions where the compound mixture of formula IId is converted to the composition of formula I and a chiral amino acid of formula IIa, and the lower alkyl ketone is converted to a lower secondary alcohol. 2 . The process of claim 1 , wherein the compound mixture of IId is a racemic mixture of formula IIe: 3 . The process of claim 1 , wherein the amino acid dehydrogenase comprises an L-amino acid dehydrogenase and the chiral amino acid of formula IIa is IIc wherein the chiral amino acid of formula IIc is present in enantiomeric excess. 4 . The process of claim 3 , wherein the L-amino acid dehydrogenase is from Bacillus, Clostridium, Corynebacterium, Geobacillus, Natronobacterium, Synechocystis, Thermoactinomyces, Thermos, Thermomicrobium , or Carderia. 5 . The process of claim 4 , wherein the L-amino acid dehydrogenase is selected from L-alanine dehydrogenase, L-aspartate dehydrogenase, L-erythro-3,5-diaminohexanoate dehydrogenase, L-leucine dehydrogenase, L-glutamate dehydrogenase, lysine dehydrogenase, L-phenylalanine dehydrogenase, L-serine dehydrogenase. L-valine dehydrogenase, L-2,4-diaminopentanoate dehydrogenase, L-glutamate synthase, L-diaminopimelate dehydrogenase, L-N-methylalanine dehydrogenase, L-lysine 6-dehydrogenase, and L-tryptophan dehydrogenase. 6 . The process of claim 1 , wherein the amino acid dehydrogenase comprises a D-amino acid dehydrogenase and the chiral amino acid of formula IIa is IIb wherein the chiral amino acid of formula of formula IIa is present in enantiomeric excess. 7 . The process of claim 6 , wherein the D-amino acid dehydrogenase is from Halobacterium, Methanosarcina, Pseudomonas, Pyrobaculum, Salmonella, Corynebacterium , and Escherichia. 8 . The process of claim 7 , wherein the D-amino acid dehydrogenase is from Pseudomonas aeruginosa, Pseudomonas fluorescens, Pyrobaculum islandicum, Salmonella typhimurium, Corynebacterium glutamicum , and Escherichia coli. 9 . The process of claim 8 , wherein the D-amino acid dehydrogenase is selected from D-alanine dehydrogenase, D-threonine dehydrogenase, and D-proline dehydrogenase. 10 . The process of claim 1 which is carried out in a cell free system. 11 . The process of claim 1 , wherein the amino acid dehydrogenase is present as a crude extract. 12 . The process of claim 1 , wherein the amino acid dehydrogenase is substantially purified. 13 . The process of claim 1 , wherein the ketoreductase is a wild type ketoreductase or an engineered ketoreductase. 14 . The process of claim 13 , wherein the ketoreductase is from Lactobacillus, Candida, Novosphingobium , or Saccharomyces. 15 . The process of claim 14 , wherein the ketoreductase of Lactobacillus is from Lactobacillus kefir, Lactobacillus brevis , or Lactobacillus minor. 16 . The process of claim 15 , wherein the ketoreductase of Candida is from Candida magnoliae. 17 . The process of claim 15 , wherein the ketoreductase of Saccharomyces is from Saccharomyces cerevisiae. 18 . The process of claim 15 , wherein the ketoreductase of Novosphingobium is from Novosphingobium aromaticivorans. 19 . The process of claim 1 , wherein the ketoreductase is an engineered ketoreductase characterized by increased thermostability, increased solvent stability, and/or increased enzymatic activity relative to the wild type ketoreductase. 20 . The process of claim 1 , wherein the ketoreductase comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, and 24. 21 . The process of claim 1 , wherein the amino acid sequence is the amino acid sequence of SEQ ID NO:18. 22 . The process of claim 1 , wherein the ketoreductase is present as a crude extract. 23 . The process of claim 1 , wherein the ketoreductase is substantially purified. 24 . The process of claim 1 , further comprising the step of removing the lower secondary alcohol formed from the lower alkyl ketone from the reaction medium. 25 . The process of claim 1 , wherein the lower alkyl ketone is acetone and the lower secondary alcohol is isopropanol. 26 . The process of claim 25 , wherein the isopropanol is removed from the reaction medium. 27 . The process of claim 1 , wherein the reaction medium is at a pH of about 8.5 to about 10. 28 . The process of claim 27 , wherein the reaction medium is at a pH of about 8.5 to about 9.0. 29 . The process of claim 1 , wherein the reaction medium is at a temperature of about 25° C. to about 45° C. 30 . The process of claim 29 , wherein the reaction medium is at a temperature of about 35° C. to about 40° C. 31 . The process of claim 1 , wherein the lower alkyl ketone is present in at least 1.5 fold stoichiometric excess of the substrate of formula IIc.

Assignees

Inventors

Classifications

  • C12P41/007Primary

    by reactions involving acyl derivatives of racemic amines · CPC title

  • Oxidoreductases acting on the CH-OH group of donors (1.1) · CPC title

  • Oxidoreductases (1.) · CPC title

  • C12P13/06Primary

    Alanine; Leucine; Isoleucine; Serine; Homoserine · CPC title

  • with NAD or NADP as acceptor (1.4.1) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016281119A1 cover?
The present disclosure relates to the use of an amino acid dehydrogenase in combination with a cofactor regenerating system comprising a ketoreductase. In particular embodiments, the process can be used to prepare L-tert-leucine using a leucine dehydrogenase.
Who is the assignee on this patent?
Codexis Inc
What technology area does this patent fall under?
Primary CPC classification C12P41/007. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Sep 29 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).